Jefferies Group LLC Agios Pharmaceuticals, Inc. Put Options Transaction History

Jefferies Group LLC

12 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2021 Sep 21, 2023	BUY	$29.58 - $49.78 $198,186 - $333,526	6,700 Added 65.05%	17,000 $558,000
Q4 2021 Feb 14, 2022	BUY	$29.58 - $49.78 $502,860 - $846,260	17,000 New	17,000 $559,000
Q3 2021 Nov 15, 2021	SELL	$41.92 - $58.18 $431,776 - $599,254	-10,300 Closed	0 $0
Q2 2021 Sep 21, 2023	SELL	$52.06 - $61.27 $3.11 Million - $3.66 Million	-59,700 Reduced 85.29%	10,300 $567,000
Q2 2021 Aug 20, 2021	SELL	$52.06 - $61.27 $53.1 Million - $62.5 Million	-1,019,700 Reduced 99.0%	10,300 $568,000
Q2 2021 Aug 16, 2021	BUY	$52.06 - $61.27 $53.6 Million - $63.1 Million	1,030,000 New	1,030,000 $568,000
Q1 2021 May 14, 2021	SELL	$44.23 - $57.5 $3.1 Million - $4.03 Million	-70,000 Closed	0 $0
Q4 2020 Sep 21, 2023	BUY	$33.21 - $46.54 $2.32 Million - $3.26 Million	70,000 New	70,000 $3.03 Million
Q4 2020 Feb 16, 2021	BUY	$33.21 - $46.54 $1.66 Million - $2.33 Million	50,000 Added 250.0%	70,000 $3.03 Million
Q3 2020 Nov 13, 2020	SELL	$33.87 - $55.93 $338,700 - $559,300	-10,000 Reduced 33.33%	20,000 $700,000
Q4 2019 Feb 13, 2020	SELL	$30.08 - $50.59 $1.05 Million - $1.77 Million	-35,000 Reduced 53.85%	30,000 $1.43 Million
Q3 2019 Nov 13, 2019	BUY	$32.4 - $49.58 $2.11 Million - $3.22 Million	65,000 New	65,000 $2.11 Million

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.89B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.